Effectiveness of Pain Neuroscience Education Along With Neural Mobilization Versus Neural Mobilization Alone on Pain, Functional Disability And Quality of Life In Patients With Diabetic Neuropathic Pain
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a randomized controlled trial aims to evaluate the comparative effect of Pain Neuroscience Education combined with neural mobilization versus neural mobilization alone in patients with diabetic neuropathic pain. This study will Compare pain intensity between intervention groups and assess functional disability outcomes. Furthermore, this will evaluate changes in quality of life and to analyze pain-related beliefs following PNE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2026
CompletedFirst Posted
Study publicly available on registry
July 10, 2026
CompletedStudy Start
First participant enrolled
July 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 20, 2027
July 10, 2026
July 1, 2026
6 months
July 6, 2026
July 6, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Pain intensity
Pain intensity will be evaluated using Numeric Pain Rating Scale
Baseline to week 6
Functional disability
Functional disability will be evaluated using Urdu version of Lower Extremity Functional Scale (LEFS)
Baseline to week 6
Quality of life
Quality of life will be evaluated by World Health Organization Quality Of Life-BREF
Baseline to week 6
Central sensitization
Central sensitization will be evaluated using Central Sensitization Inventory
Baseline to week 6
Study Arms (2)
Group A - Pain Neurosciences Education combined with Neural Mobilization
EXPERIMENTALPain neuroscience education (PNE) will be delivered through structured educational sessions focusing on pain physiology, neural sensitization, and pain modulation. PNE: 20-30 min (weeks 1-2) → 10 min reinforcement (weeks 3-6) Methods: Simple diagrams, patient-friendly metaphors, video demonstrations. Neural mobilization techniques will be applied following standardized neurodynamic principles and patients' tolerance. Target nerves: Sciatic, tibial \& common peroneal Technique: Slider neurodynamic mobilization Dosage: 10-15 reps × 2-3 sets \| Rest: 30-60 sec between sets Session duration: 15-20 minutes
Group B - Neural Mobilization Alone
ACTIVE COMPARATORNeural mobilization techniques will be applied following standardized neurodynamic principles and patients' tolerance. Target nerves: Sciatic, tibial \& common peroneal Technique: Slider neurodynamic mobilization Dosage: 10-15 reps × 2-3 sets \| Rest: 30-60 sec between sets Session duration: 15-20 minutes
Interventions
In Group A pain neuroscience Education will be given in adjunct with neural mobilization techniques Target nerves: Sciatic, tibial \& common peroneal Technique: Slider neurodynamic mobilization Dosage: 10-15 reps × 2-3 sets \| Rest: 30-60 sec between sets Session duration: 15-20 minutes PNE: 20-30 min (weeks 1-2) → 10 min reinforcement (weeks 3-6) Methods: Simple diagrams, patient-friendly metaphors, video demonstrations
Eligibility Criteria
You may qualify if:
- Age ≥ 40 years (WHO 2016 criteria) Diagnosed Type II diabetes mellitus Lower limb neuropathic pain ≥ 3 months Pain intensity ≥ 4/10 on NPRS Able to walk independently and follow instructions
You may not qualify if:
- Neurological disorders (e.g. stroke, Guillain-Barré) Lumbar disc herniation with radiculopathy Lower limb surgery or spinal fracture within 6 months Active diabetic foot ulcer Diagnosed cognitive impairment or severe infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Positive Solution Clinic, Wah Cantt
Rawalpindi, Punjab Province, 46000, Pakistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2026
First Posted
July 10, 2026
Study Start
July 10, 2026
Primary Completion (Estimated)
January 10, 2027
Study Completion (Estimated)
January 20, 2027
Last Updated
July 10, 2026
Record last verified: 2026-07